The Castrate Resistant Prostate Cancer Market is Propelled by Rising Prevalence Of Prostate Cancer
by Castrate resistant prostate cancer (CRPC) refers to prostate cancer that continues to progress even after medical or surgical therapy lowers testosterone levels. Drugs used in …